VLS-1488 for endometrial neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 15 Jun 2023: Trial registered, NCT05902988
  2. 18 Oct 2023: Trial started, NCT05902988

The trials

NCT05902988: A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

State
Under way
Phase
Phase 1 and Phase 2
People
200 planned
Started
18 Oct 2023
Primary completion
Jun 2026
Arms
Dose Escalation: Dose Escalation Cohorts, Dose Escalation: Backfill Cohorts, Dose Expansion: Exploration Cohorts, Dose Expansion: Development Cohorts
Results
None posted
  1. 15 Jun 2023: Trial registered
  2. 18 Oct 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.